Developing tools to predict antimicrobial resistance gene and mobile genetic element profiles from metagenomic analysis and demographic data

开发工具根据宏基因组分析和人口统计数据预测抗菌素耐药性基因和移动遗传元件谱

基本信息

  • 批准号:
    1754536
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Studentship
  • 财政年份:
    2016
  • 资助国家:
    英国
  • 起止时间:
    2016 至 无数据
  • 项目状态:
    已结题

项目摘要

The goal of my PhD is to create a tool to predict the profiles of antimicrobial resistance (AMR) in humans using insights from metagenomic data, and other demographics, such as lifestyle, location and socio-economic status. The PhD will include multiple investigations into different metrics for the prediction tool that can act as independent projects, making this PhD strategy flexible and robust. The World Health Organisation describes AMR as "one of the biggest threats to global health, food security, and development today". Common bacterial infections are becoming untreatable by antibiotics due to antibiotic resistance, especially in countries such as India and China, where antibiotic over-use and misuse are common. AMR genes have not only been identified from AMR infections, but also in saliva and stool samples from healthy individuals (Diaz-Torres et al., 2006, Pehrsson et al., 2016). Microbes in healthy individuals may acquire AMR genes through: association with mobile genetic elements (MGE) that undergo horizontal gene transfer (HGT) from microbes in the environment, especially from overcrowded living conditions, poor sanitation and farming where antimicrobial drugs are constantly administered to animals; and misuse of antibiotics from a previous infection i.e. not completing the course. Quantifying AMR status of individuals across the globe could have a significant impact on targeting policies most rapidly to those areas with populations at high risk of AMR, for example, earlier surveillance of potential AMR infections and regulating the use of certain antibiotics. To be able to treat infections quickly and efficiently, health professionals need to prescribe antibiotics that will be completely effective after a first course of treatment. Since AMR is becoming so prevalent, it is important for healthcare professionals to know whether an individual is likely to be at risk of expressing a certain AMR gene and whether this gene could lead to an antibiotic being ineffective against an infection. If this is known, alternative antibiotics or even bacteriophage 1 treatments could be used instead as a first course of treatment. So far, there is no universal profiling tool for AMR. However, research into AMR gene prediction tools and AMR severity scores for worldwide surveillance is already underway by Prof Andrew McArthur and collaborators in Hamilton, Canada, and draft software will be created within the year (personal correspondence). Because of this, I feel it is necessary to focus on a prediction tool that can benefit future diagnosis as well as surveillance. I plan to create a tool that will aim to predict an individual's AMR profile and association with MGEs based on 1) parameters of microbial diversity: species abundance, richness and co-occurrence, 2) demographics, such as profession and location, and 3) how this information could be applied to antimicrobial resistance diagnosis in the future.
我的博士学位的目标是创建一种工具,利用宏基因组数据和其他人口统计数据(如生活方式,位置和社会经济地位)的见解来预测人类的抗菌素耐药性(AMR)概况。博士将包括对预测工具的不同指标的多项调查,这些指标可以作为独立的项目,使这个博士策略灵活而强大。世界卫生组织将抗生素耐药性描述为“当今全球健康、粮食安全和发展的最大威胁之一”。由于抗生素耐药性,常见的细菌感染变得无法用抗生素治疗,特别是在印度和中国等国家,抗生素过度使用和滥用很常见。不仅从AMR感染中鉴定出AMR基因,而且在来自健康个体的唾液和粪便样品中也鉴定出AMR基因(Diaz-Torres et al.,2006年,Pehrsson等人,2016年)。健康个体中的微生物可能通过以下方式获得AMR基因:与环境中微生物进行水平基因转移(HGT)的移动的遗传元件(MGE)相关联,特别是过度拥挤的生活条件,卫生条件差和不断向动物施用抗菌药物的农业;以及滥用既往感染的抗生素,即未完成疗程。量化地球仪个体的AMR状态可能会对最快针对AMR高风险人群地区的政策产生重大影响,例如早期监测潜在的AMR感染和规范某些抗生素的使用。为了能够快速有效地治疗感染,卫生专业人员需要在第一个疗程后开出完全有效的抗生素。由于AMR变得如此普遍,医疗保健专业人员必须了解个体是否可能有表达某种AMR基因的风险,以及该基因是否会导致抗生素对感染无效。如果这是已知的,替代抗生素甚至噬菌体1治疗可以作为第一个疗程。到目前为止,还没有通用的AMR分析工具。然而,Andrew McArthur教授和加拿大汉密尔顿的合作者已经在进行AMR基因预测工具和AMR严重程度评分的研究,并将在年内创建软件草案(个人通信)。正因为如此,我觉得有必要专注于一个预测工具,可以有利于未来的诊断和监测。我计划创建一个工具,旨在预测个人的AMR概况和与MGE的关联,基于1)微生物多样性参数:物种丰度,丰富度和共生,2)人口统计学,如职业和位置,以及3)这些信息如何应用于未来的抗菌素耐药性诊断。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

其他文献

吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
生命分子工学・海洋生命工学研究室
生物分子工程/海洋生物技术实验室
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:

的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('', 18)}}的其他基金

An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
  • 批准号:
    2901954
  • 财政年份:
    2028
  • 资助金额:
    --
  • 项目类别:
    Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
  • 批准号:
    2896097
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
  • 批准号:
    2780268
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
  • 批准号:
    2908918
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
  • 批准号:
    2908693
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
  • 批准号:
    2908917
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
  • 批准号:
    2879438
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
  • 批准号:
    2890513
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
  • 批准号:
    2879865
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
  • 批准号:
    2876993
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship

相似海外基金

DEVELOPING TRUSTWORTHY ARTIFICIAL INTELLIGENCE (AI)- DRIVEN TOOLS TO PREDICT VASCULAR DISEASE RISK AND PROGRESSION - VASCULAID
开发值得信赖的人工智能 (AI) 驱动工具来预测血管疾病风险和进展 - VASCULAID
  • 批准号:
    10079480
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
Developing High-Quality Tools to Characterize Allograft Quality, Predict Transplant Outcomes and Expand Access to Kidney and Liver Transplantation
开发高质量工具来表征同种异体移植质量、预测移植结果并扩大肾移植和肝移植的机会
  • 批准号:
    10201592
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Developing High-Quality Tools to Characterize Allograft Quality, Predict Transplant Outcomes and Expand Access to Kidney and Liver Transplantation
开发高质量工具来表征同种异体移植质量、预测移植结果并扩大肾移植和肝移植的机会
  • 批准号:
    10605254
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Developing High-Quality Tools to Characterize Allograft Quality, Predict Transplant Outcomes and Expand Access to Kidney and Liver Transplantation
开发高质量工具来表征同种异体移植质量、预测移植结果并扩大肾移植和肝移植的机会
  • 批准号:
    10413907
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
18F-NaF PET-CT Imaging and Blood Biomarker Analysis as Tools to Predict Patients at Risk of Developing Severe Aortic Valve Calcification
18F-NaF PET-CT 成像和血液生物标志物分析作为预测患者发生严重主动脉瓣钙化风险的工具
  • 批准号:
    441253
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Fellowship Programs
Developing Population-Based Risk Tools to Predict and Reduce Premature Mortality in Canadian Cities
开发基于人口的风险工具来预测和减少加拿大城市的过早死亡率
  • 批准号:
    417003
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
    Studentship Programs
Developing New Computer Modelling Tools to Better Predict the Reactivity of Active Site Cysteines in Protein Kinases for Optimizing Anti-cancer Drugs
开发新的计算机建模工具以更好地预测蛋白激酶中活性位点半胱氨酸的反应性以优化抗癌药物
  • 批准号:
    517792-2017
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
    Vanier Canada Graduate Scholarship Tri-Council - Doctoral 3 years
Developing New Computer Modelling Tools to Better Predict the Reactivity of Active Site Cysteines in Protein Kinases for Optimizing Anti-cancer Drugs
开发新的计算机建模工具以更好地预测蛋白激酶中活性位点半胱氨酸的反应性以优化抗癌药物
  • 批准号:
    517792-2017
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
    Vanier Canada Graduate Scholarship Tri-Council - Doctoral 3 years
Developing Tools That Predict Use of Breast Cancer Screening and Stage at Breast Cancer Diagnosis
开发预测乳腺癌筛查和乳腺癌诊断分期使用的工具
  • 批准号:
    365162
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
Developing New Computer Modelling Tools to Better Predict the Reactivity of Active Site Cysteines in Protein Kinases for Optimizing Anti-cancer Drugs
开发新的计算机建模工具以更好地预测蛋白激酶中活性位点半胱氨酸的反应性以优化抗癌药物
  • 批准号:
    517792-2017
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
    Vanier Canada Graduate Scholarship Tri-Council - Doctoral 3 years
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了